Regenerative Medicine

Stem Cells.

Repair. Restore. Renew.

Advanced regenerative solutions using Mesenchymal Stem Cells to support your body's natural healing, improve function, and enhance quality of life.

Microscopic stem cell illustration

What are Mesenchymal Stem Cells?

MSCs are natural cells found in the body with the unique ability to repair, regenerate and modulate the immune system.

Learn more

Umbilical-Derived Mesenchymal Stem Cells

Sourced from healthy umbilical tissue, these cells are rich in growth factors, non-invasive to obtain and have strong regenerative potential.

Learn more

How Does It Work?

MSCs release bioactive factors that reduce inflammation, promote tissue repair, support angiogenesis and regulate the immune response.

Learn more

Applications of Use

From joint pain and injury recovery to auto-immune conditions and anti-ageing support—MSCs have a wide range of therapeutic uses.

View applications

Safe & Ethical

Screened, tested and ethically sourced.

Evidence-Based

Backed by scientific research and clinical studies.

Premium Quality

Processed in accredited facilities.

Expert Care

Personalised protocols by experienced doctors.

Section 01

What are Mesenchymal Stem/Stromal Cells?

Mesenchymal stromal cells, commonly referred to as mesenchymal stromal cells or MSCs, are multipotent cells that can be isolated from several human tissues.

Rather than simply turning into new tissue, much of the current scientific interest in MSCs relates to the biological signals they release and their interactions with surrounding cells.

These signalling effects are being investigated for their potential roles in:

  • Modulating inflammatory responses
  • Immune regulation
  • Supporting tissue-repair processes
  • Cellular communication
  • Angiogenic signalling

Section 02

Umbilical-Derived Mesenchymal Stromal Cells

Umbilical-derived MSCs are obtained from donated perinatal tissue, including umbilical cord tissue, following appropriate donor screening and processing.

These cells are of significant interest in regenerative medicine because of their biological characteristics, proliferative capacity and secretion of signalling molecules.

Quality, sterility, donor screening, cell characterisation, manufacturing standards and regulatory compliance are important considerations when evaluating any cell-based product.

  • Donor screening
  • Quality & sterility
  • Cell characterisation
  • Manufacturing standards
  • Regulatory compliance

Section 03

How Does It Work?

MSCs appear to exert many of their effects through paracrine signalling — communicating with surrounding cells by releasing biologically active substances.

These include growth factors, cytokines and extracellular vesicles.

Through these signalling pathways, MSCs are being investigated for their potential influence on:

  • Inflammatory pathways
  • Immune responses
  • Tissue repair and remodelling
  • Angiogenesis
  • Cellular recovery and communication

Research into these mechanisms and their clinical significance is ongoing.

Section 04

Applications of MSC Therapy

MSC-based therapies are being investigated across multiple areas of medicine.

Musculoskeletal & Orthopaedic

Osteoarthritis, cartilage injury, tendon and ligament disorders and other musculoskeletal conditions.

Inflammatory & Immune-Mediated Conditions

Research is investigating the immunomodulatory properties of MSCs in several inflammatory and immune-mediated diseases.

Tissue Repair & Recovery

Potential applications involving wound healing and tissue-repair signalling are under investigation.

Other Emerging Applications

Research continues into neurological, cardiovascular, pulmonary and other potential applications.

Important medical context

Not all potential applications of MSCs are established or approved treatments. Evidence varies significantly by condition, cell source, preparation and method of administration.

A medical consultation is required to determine whether a regenerative treatment is appropriate and to discuss available evidence, potential benefits, limitations, alternatives and risks.

Safety & Quality

Responsible Regenerative Medicine

Cell-based therapies require careful patient selection and appropriate clinical governance.

Patient Screening

Individual medical assessment before treatment.

Quality & Traceability

Clear documentation of cell source, processing, storage and traceability.

Sterility & Testing

Appropriate microbiological, quality and product testing.

Evidence-Informed Care

Recommendations based on the available scientific evidence and the patient's individual circumstances.

Informed Consent

Clear discussion of potential benefits, uncertainties, alternatives and risks.

Regulatory Compliance

Cell-based therapies should only be offered within the applicable South African regulatory and ethical framework.

FAQ

Common questions

Are stem cell therapies a proven treatment for every condition listed? +

No. MSC-based therapies are being investigated across several areas of medicine. Not every potential application is an established or approved treatment, and evidence varies by condition, cell source, preparation and method of administration.

Do mesenchymal stem cells replace damaged organs or guarantee repair? +

No. Current scientific interest focuses largely on biological signalling — including inflammation, immune regulation and tissue-repair processes — rather than guaranteed regeneration. Research into these mechanisms is ongoing.

Who decides whether regenerative treatment is appropriate? +

A medical consultation is required. Your doctor will review your condition, the available evidence, potential benefits, limitations, alternatives and risks before any recommendation is made.

Where do umbilical-derived MSCs come from? +

Umbilical-derived MSCs are obtained from donated perinatal tissue, including umbilical cord tissue, following appropriate donor screening and processing. Quality, sterility, characterisation and regulatory compliance are essential considerations.

Is this offered within South African regulations? +

Cell-based therapies should only be offered within the applicable South African regulatory and ethical framework, with patient screening, informed consent and appropriate clinical governance.

Interested in Regenerative Medicine?

Book a consultation to discuss your condition, review the available evidence and determine whether a regenerative approach may be appropriate for you.